Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Focal alopecia in dogs has many causes and requires various tests for accurate diagnosis and treatment.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

The dog's skin and anemia issues returned after stopping treatment for Babesia gibsoni.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Type I interferons play a key role in the development of various skin diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.